|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07J 63/00 | (2006.01) |
| C07J 63/008 | (2013.01) | ||
| A61K 31/56 | (2006.01) | ||
| A61P 5/40 | (2006.01) |
| (11) | Number of the document | 3921327 |
| (13) | Kind of document | T |
| (96) | European patent application number | 20709101.8 |
| Date of filing the European patent application | 2020-02-06 | |
| (97) | Date of publication of the European application | 2021-12-15 |
| (45) | Date of publication and mention of the grant of the patent | 2023-04-05 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2020/017077 |
| Date | 2020-02-06 |
| (87) | Number | WO 2020/163642 |
| Date | 2020-08-13 |
| (30) | Number | Date | Country code |
| 201962802210 P | 2019-02-07 | US |
| (72) |
DRAGOLI, Dean , US
LUEHR, Gary , US
CHEN, Tao , US
LEWIS, Jason , US
LEADBETTER, Michael , US
|
| (73) |
Ardelyx, Inc. ,
34175 Ardenwood Blvd., Suite 200, Fremont, California 94555,
US
|
| (54) | GLYCYRRHETINIC ACID DERIVATIVES FOR USE IN TREATING HYPERKALEMIA |
| GLYCYRRHETINIC ACID DERIVATIVES FOR USE IN TREATING HYPERKALEMIA |